
Home / Clinics Supported / Aesthetics
Many markets still have room for a med spa patients choose by name. ACG helps you open the one built to win. In most states, no medical background is required to own the business; an independent, state-licensed Medical Director directs all clinical care. Some states require physician ownership, and ACG structures for yours.
Book a Strategy CallU.S. searches for “med spa near me” run 100,000 to 1 million a month (Google Keyword Planner), and AmSpa puts med spa revenue above $17 billion, growing by more than $1 billion a year. There is room, but not for another generic med spa.
The med spas that struggle sell the same services at similar prices. The ones that win build an identity patients choose by name and refer, and with ACG that brand is yours. A med spa franchise licenses you its brand and charges royalties for the life of the agreement; see the independent clinic vs. franchise comparison.
ACG validates your market before you commit capital, step one of our clinic launch program, and only builds clinics it believes can win where they open.
Recurring visits: neurotoxin patients who trust their injector tend to return every 3 to 4 months
Strong average ticket: packages and combination protocols lift revenue per visit
Referral growth: a patient who loves their results tends to tell the people around them
Price insulation: patients choose by name, not by who runs the cheapest Botox special
The core menu, and the adjacent services patients add over time.
The category anchor: 9.9 million U.S. neuromodulator injections in 2024, more than any other minimally invasive cosmetic procedure (ASPS). Many patients start here.
Lip, cheek, jawline and under-eye fillers: premium pricing and a strong word-of-mouth driver.
Laser resurfacing, chemical peels and PRP microneedling, sold as treatment series. For PRP elsewhere, see Joint & Musculoskeletal and Hair Regeneration.
Non-surgical fat reduction and body sculpting, a high-ticket service.
Hydration and vitamin IV protocols, plus medical-grade skincare that earns revenue between appointments. For a full IV menu, see IV Therapy & Infusion.
Patients who trust their provider are natural candidates for lines ACG can help you add as the clinic matures: Hormone Optimization, Medical Weight Loss and Longevity.
Corporate practice of medicine rules bite hard in aesthetics. Several states require a physician to own the practice or a management-company structure, injector and aesthetician scope of practice follows state rules, and LegitScript certification affects where you can advertise.
ACG navigates all of it. The operator who gets this right from the start builds a clinic that scales. The one who skips it builds a liability.
Demand, competitors and pricing in your market, mapped before you commit capital.
Your state's ownership rules, a management-company structure where required, the Medical Director agreement and liability insurance.
Neurotoxin, filler, equipment and skincare suppliers at preferred pricing through ACG's vendor network.
Injector hiring criteria, scope-of-practice compliance and consultation sales training.
A brand identity patients choose by name and a marketing strategy built for aesthetics ad rules, including LegitScript. Marketing execution is a separate engagement.
The questions founders ask before opening a med spa. Anything else, ask on the strategy call. No pressure, no pitch.
View All FAQs
Talk with Grayson Miller about med spa demand in your market, your service mix and what opening takes. No pitch. No obligation.
ACG is a consulting and advisory firm, not a medical practice; an independent, state-licensed Medical Director directs all clinical care. Results are not guarantees of income. Individual outcomes vary. The 60-day target begins from clinic keys received, market and regulatory conditions permitting.
Knowing the rules is the foundation of every clinic we help launch.
You own and run the business. An independent, state-licensed Medical Director makes every clinical, prescribing and treatment decision, structured for your state's Corporate Practice of Medicine laws. We connect you to a vetted network; you retain your own provider.
PRP, peptides, GLP-1 medications and cellular products each carry federal and state rules, and not every product or use is FDA-approved. Exosomes for therapeutic use are not FDA-approved at all, and we steer you away from them. Your menu and marketing are built to hold up to FDA, FTC and state medical board scrutiny.
We show real ranges and never promise an income or a clinical outcome. What you earn depends on your market, your capital and your execution.
Altos Consulting Group is a business consulting and advisory firm, not a medical practice, and does not provide, prescribe or sell any drug, biologic, device or therapy. The FDA has stated there are currently no FDA-approved exosome products for the treatment of any disease; clinic owners are responsible for the compliance of every product, therapy and claim. See the full regulatory notice below.